NCT01236586: RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia |
|
|
| Withdrawn | 1/2 | 0 | US | RO4929097, Dexamethasone | National Cancer Institute (NCI) | Lymphoma, Brain Neoplasms, Sarcoma, Osteosarcoma, Wilm's Tumor | 04/11 | 04/11 | | |
